Novostia
Switzerland - LausanneBiotechnology
Focus: Novostia is a Swiss-based biotechnology company specializing in artificial heart valves for cardiovascular and metabolic disease treatment. The company operates at a pre-revenue or early-stage development phase with minimal public disclosure of scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Novostia
AI assessmentNot HiringNo open roles listed right now. Follow Novostia to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TRIFLO Heart Valve
Aortic Valve DiseaseClinical Trials (1)
NCT06119607PILot Aortic Triflo Valve Study
N/AHelp build intelligence for Novostia
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.